Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis

Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis

Background: The information is relatively scarce regarding the occurrence of drug-induced acute kidney injury (AKI) when anti-coronavirus disease 2019 (COVID-19) drugs are prescribed for patients with diabetes mellitus (DM).Objective: The objective of this study was to evaluate a pharmacovigilance s...

Full description

Bibliographic Details
Main Authors:	Yu Zhou, Jianbin Li, Linyao Wang, Xinyan Zhu, Meilian Zhang, Jiaping Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	pharmacovigilance acute kidney injury COVID-19 diabetes mellitus drug adverse drug reaction
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.833679/full

Similar Items

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database
by: Giuseppe Cicala, et al.
Published: (2024-10-01)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system
by: Qiong Jie, et al.
Published: (2024-09-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

National strategy for the integration of pharmacovigilance in the Moroccan TB Control Program
by: Driss Soussi Tanani, et al.
Published: (2017-01-01)

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
by: Michele Fusaroli, et al.
Published: (2024-11-01)

Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
by: Lulu Liu, et al.
Published: (2022-12-01)

Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01)

A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
by: Yikuan Du, et al.
Published: (2024-10-01)

IV Ciprofloxacin-Induced Phlebitis: Investigating the Impact of Pharmaceutical and Process-Related Factors on Patient Safety
by: Sareh Hosseini, et al.
Published: (2024-10-01)

Challenges and experiences in establishing a zonal pharmacovigilance centre at Bangabandhu Sheikh Mujib Medical University: A 10-month journey
by: Elora Sharmin, et al.
Published: (2024-03-01)

Role of hospital pharmacists in reporting adverse drug reactions – A review
by: Sharmila P Nirojini, et al.
Published: (2012-01-01)

Las reacciones adversas a medicamentos: una aproximación desde el punto de vista económico.
by: Omar Segura, et al.
Published: (2003-12-01)

Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital
by: Pamela Alejandra Saavedra, et al.

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
by: Maria Antonietta Barbieri, et al.
Published: (2019-10-01)

Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system
by: Chengyu Zhu, et al.
Published: (2025-03-01)

Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review
by: Chia-Hao Chang, et al.
Published: (2023-02-01)

Assessment of knowledge, practices, and barriers to pharmacovigilance among nurses at a teaching hospital, Ghana: a cross‑sectional study
by: Paa Kofi Tawiah Adu-Gyamfi, et al.
Published: (2022-08-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Empowering Patient Safety: Assessment of Adverse Drug Reaction Knowledge and Practice Among Pharmacy Professionals
by: Josipa Bukić, et al.
Published: (2024-12-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Adverse Drug Reactions of Antiepileptic Drugs in Neurology Department of M.Y.H Indore, India: An Observational, Prospective Study
by: Saman Hussain, et al.
Published: (2023-04-01)

Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices
by: Mohit Hans, et al.
Published: (2018-01-01)

Bir eğitim hastanesinde farmakovijilans merkezine yönlendirilen yatan hastalardaki advers ilaç reaksiyonlarının analizi
by: Zakir Khan, et al.
Published: (2020-06-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

PROSPECTIVE MONITORING OF DRUG USE: DRUG-INDUCED LIVER INJURY IN A PRIMARY HEALTHCARE CENTER
by: Nília Maria de Brito Lima PRADO, et al.
Published: (2019-11-01)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
by: Fabrizio Calapai, et al.
Published: (2023-10-01)

Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis
by: Zheng Zhang, et al.
Published: (2024-07-01)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023-10-01)

Knowledge, attitude, and practice study of pharmacovigilance in a dental teaching institute in Western India
by: Rashmi Venkatesh, et al.
Published: (2024-10-01)

Evaluation of knowledge, attitude, and practice of adverse drug reactions reporting among doctors and nursing staff of a rural tertiary care teaching hospital of Maharashtra
by: Satish E Bahekar, et al.
Published: (2018-01-01)

SIGNIFICANCE OF PHARMACOVIGILANCE AND ITS CLINICAL IMPLICATIONS
by: Susanta Kumar Bandyopadhyay, et al.
Published: (2016-12-01)

Current status and future prospects of pharmacovigilance in Pakistan
by: Rabia Hussain, et al.
Published: (2019-12-01)

Adverse Drug Reactions Reported in Healthcare Settings Affiliated to Mazandaran University of Medical Sciences, 2019-2021
by: Mina Amini, et al.
Published: (2023-09-01)

Cutaneous adverse drug reactions in a tertiary care setup: A cross-sectional observational single-center-based study in Eastern India
by: Ritika Singh, et al.
Published: (2023-01-01)

Pharmacovigilance Activities in Maulana Azad Medical College and Associated Hospitals: A Step towards Patient Safety
by: Vandana Roy, et al.
Published: (2023-01-01)

Evaluation of Pharmacovigilance System in Iran
by: Malahat Khalili, et al.
Published: (2022-07-01)

Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting
by: Faris El-Dahiyat, et al.
Published: (2023-07-01)

Adverse Drug Reactions in Mazandaran Province, Iran, 2004-2018
by: Fatemeh Izadpanah, et al.
Published: (2020-05-01)

An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital
by: Saloni Amin, et al.
Published: (2018-01-01)